Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herweijer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Vaccine|March 11, 2018
Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in SwedenEva Herweijer, Alexander Ploner, Pär Sparén
Preventive Medicine|December 28, 2020
Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccinationKarin Sundström, Eva Herweijer, Jiangrong Wang
JAMA|June 19, 2014
Number of human papillomavirus vaccine doses and condyloma--replyAlexander Ploner, Eva Herweijer, Lisen Arnheim-Dahlström
International Journal of Cancer|May 4, 2017
Reply to Ryser et alKarin Sundström, Eva Herweijer, Pär Sparén, et al.
The Journal of Infectious Diseases|January 29, 2025
Population-level Impact of HPV Vaccination on the Incidence of Genital Warts in SwedenAna Martina Astorga Alsina, Eva Herweijer, Jiayao Lei
Current Opinion in Oncology|November 20, 2013
Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a reviewKlara Miriam Elfström, Eva Herweijer, Karin Sundström, et al.
International Journal of Cancer|February 10, 2016
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based studyEva Herweijer, Karin Sundström, Alexander Ploner, et al.
Gastro Hep Advances|August 12, 2024
Evaluation of Heterologous Effects of Travel Vaccines in Colorectal Cancer: A Database Study and a Cautionary TaleEva Herweijer, Klaus Schwamborn, Kaatje Bollaerts, et al.
Preventive Medicine Reports|August 16, 2023
High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012-2019Jiangrong Wang, Eva Herweijer, Sara Nordqvist Kleppe, et al.
The Journal of Infectious Diseases|July 21, 2012
Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availabilityAmy Leval, Eva Herweijer, Lisen Arnheim-Dahlström, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|March 11, 2018
Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in SwedenEva Herweijer, Alexander Ploner, Pär Sparén
Preventive Medicine|December 28, 2020
Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccinationKarin Sundström, Eva Herweijer, Jiangrong Wang
JAMA|June 19, 2014
Number of human papillomavirus vaccine doses and condyloma--replyAlexander Ploner, Eva Herweijer, Lisen Arnheim-Dahlström
International Journal of Cancer|May 4, 2017
Reply to Ryser et alKarin Sundström, Eva Herweijer, Pär Sparén, et al.
The Journal of Infectious Diseases|January 29, 2025
Population-level Impact of HPV Vaccination on the Incidence of Genital Warts in SwedenAna Martina Astorga Alsina, Eva Herweijer, Jiayao Lei
Current Opinion in Oncology|November 20, 2013
Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a reviewKlara Miriam Elfström, Eva Herweijer, Karin Sundström, et al.
International Journal of Cancer|February 10, 2016
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based studyEva Herweijer, Karin Sundström, Alexander Ploner, et al.
Gastro Hep Advances|August 12, 2024
Evaluation of Heterologous Effects of Travel Vaccines in Colorectal Cancer: A Database Study and a Cautionary TaleEva Herweijer, Klaus Schwamborn, Kaatje Bollaerts, et al.
Preventive Medicine Reports|August 16, 2023
High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012-2019Jiangrong Wang, Eva Herweijer, Sara Nordqvist Kleppe, et al.
The Journal of Infectious Diseases|July 21, 2012
Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availabilityAmy Leval, Eva Herweijer, Lisen Arnheim-Dahlström, et al.
Pageof 3